The results indicate that only a few RNA modification genes are relevant across multiple cancers; for example, IGF2BP3 demonstrates significant prognostic value in six cancers (Figure 2A; Table S6) and has been suggested as a diagnostic and prognostic marker for various cancers, particularly gliomas [42]. The gene discussed is IGF2BP3; the disease is central nervous system cancer.